Avisa Diagnostics Inc.
FOGCF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 120.92% | 49.23% | |||
| Depreciation & Amortization | 128.57% | 17.86% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 128.74% | 54.51% | |||
| Operating Income | -128.74% | -54.51% | |||
| Income Before Tax | -864.52% | 159.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -864.52% | 159.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -864.52% | 159.69% | |||
| EBIT | -128.74% | -54.51% | |||
| EBITDA | -130.19% | -55.07% | |||
| EPS Basic | 32.59% | 159.69% | |||
| Normalized Basic EPS | 31.72% | 154.45% | |||
| EPS Diluted | 32.59% | 159.69% | |||
| Normalized Diluted EPS | 31.72% | 154.45% | |||
| Average Basic Shares Outstanding | 1,330.05% | 0.00% | |||
| Average Diluted Shares Outstanding | 1,330.05% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||